Ross University School of Medicine graduates, colloquially known as ‘Ross Med,’ who applied for Borrower Defense to Repayment before the Nov. 3 deadline, are eligible for a federal student loan discharge under the Sweet v. Cardona class-action settlement.
This applies to students who borrowed from the U.S. government to attend any institution of higher education, including Caribbean medical schools like Ross, which is accredited by the Caribbean Accreditation Authority for Education in Medicine (CAAM-HP).
If the borrower’s loans are associated with Ross, a medical school with campuses in Dominica and Miramar, Miami, they will receive Full Settlement Relief.
This entails the discharge of federal student loan(s) linked to their attendance at the school, refund of any amounts paid to the Education Department on those loans, and deletion of the credit tradeline for those loans from the borrower’s credit report.
This is significant for Ross Med students, who typically spend a significant amount of USD to complete their medical degree program.
How the Education Department reviews applications
The Education Department will use a streamlined review process to make decisions on these applications, using the 2016 Borrower Defense Regulation. The department won’t require evidence outside of the written application, proof of reliance, or apply any statute of limitations.
If an application is not initially approved, the department will provide instructions for resubmission, and borrowers will have six months to resubmit their application for review.
Process For Post-Class Applicants
For borrowers who applied for BDR relief after Jun. 22, 2022, but before the final approval of the settlement, their applications will be reviewed using the 2016 Borrower Defense Regulation.
The Educaiton Department is required to issue a decision on these applications no later than Jan. 28, 2026. If it doesn’t, the borrowers will receive full settlement relief.
While this settlement provides potential relief, it does not denote wrongdoing by the listed institutions, including Ross. The settlement does not influence Ross’s acceptance rate, its basic and medical sciences curriculum rigor, or the hands-on clinical training that Ross prides itself on.